Clozapine: More side effects but still the best antipsychotic

Journal of Clinical Psychiatry

Volumn 71, Issue 8, 2010, Pages 982-983

  Kang, Xin ^a   Simpson, George M ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; CLOZAPINE; OLANZAPINE; QUETIAPINE; RISPERIDONE;

DRUG COST; DRUG EFFICACY; DRUG WITHDRAWAL; EVIDENCE BASED MEDICINE; EXTRAPYRAMIDAL SYMPTOM; HUMAN; HYPOTENSION; MYOCARDITIS; NEUTROPENIA; NOTE; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOSIS; SALIVATION DISORDER; SCHIZOPHRENIA; SEDATION; SEIZURE; SIDE EFFECT; STANDARD; TACHYCARDIA; WITHDRAWAL SYNDROME;

ANTIPSYCHOTIC AGENTS; BASAL GANGLIA DISEASES; CLOZAPINE; DRUG DISCOVERY; DRUG MONITORING; DRUG RESISTANCE; HUMANS; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 77955999643     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.09com05497yel     Document Type: Note

References (8)

1. Hippius H. The history of clozapine. Psychopharmacology (Berl). 1989; 99(suppl):S3-S5.
2. Simpson GM, Varga E. Clozapine: a new antipsychotic agent. Curr Ther Res Clin Exp. 1974;16(7):679-686.
3. Haase HJ. [Psychiatric experiences with megaphen (largactil) and the Rauwolfia alkaloid serpasil with special reference to Parkinson's psychomotor syndrome]. Nervenarzt. 1955;26(12):507-510.
4. Simpson GM, Lee JH, Shrivastava RK. Clozapine in tardive dyskinesia. Psychopharmacology (Berl). 1978;56(1):75-80.
5. Kane JM, Honigfeld G, Singer J, et al. Clozapine Collaborative Study Group. Clozapine for the treatment-resistant schizophrenic: results of a US multicenter trial. Psychopharmacology (Berl). 1989;99(suppl): S60-S63.
6. Ronaldson KJ, Taylor AJ, Fitzgerald PB, et al. Diagnostic characteristics of clozapine-induced myocarditis identified by an analysis of 38 cases and 47 controls. J Clin Psychiatry. 2010;71(8):976-981.
7. IMS Health. National Prescription Administrators (NPA) Audit for 2008-2009. April 2009. http://www.imshealth.com/portal/site/imshealth/menuitem. a46c6d4df3db4b3d88f611019418c22a/?vgnextoid= a4284c30aaaa0210VgnVCM100000ed152ca2RCRD&vgnextchannel=b c42650204850210VgnVCM100000ed152ca2RCRD&vgnextfmt=default. Accessed January 6, 2010.
8. Tiihonen J, Lönnqvist J, Wahlbeck K, et al. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet. 2009;374(9690):620-627.